Application 050672

Type
NDA
Sponsor
GLAXOSMITHKLINE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CEFTINCEFUROXIME AXETILFOR SUSPENSION;ORALEQ 125MG BASE/5MLYesNo
002CEFTINCEFUROXIME AXETILFOR SUSPENSION;ORALEQ 250MG BASE/5MLYesNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N050672-001CEFTINCEFUROXIME AXETILEQ 125MG BASE/5MLFOR SUSPENSION / ORALRLD1994-06-30
N050672-002CEFTINCEFUROXIME AXETILEQ 250MG BASE/5MLFOR SUSPENSION / ORALRLD1997-04-29

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N050672-001CEFTINEQ 125MG BASE/5MLFOR SUSPENSION / ORALRLD1994-06-3084e616aacf4f…
2026-09-14 22:38:342026-08N050672-002CEFTINEQ 250MG BASE/5MLFOR SUSPENSION / ORALRLD1997-04-2984e616aacf4f…
2026-08-18 06:07:402026-07N050672-001CEFTINEQ 125MG BASE/5MLFOR SUSPENSION / ORALRLD1994-06-30caaa826d4ba7…
2026-08-18 06:07:402026-07N050672-002CEFTINEQ 250MG BASE/5MLFOR SUSPENSION / ORALRLD1997-04-29caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N050672-001CEFTINEQ 125MG BASE/5MLFOR SUSPENSION / ORALRLD1994-06-30011fe1cb6892…
2026-02-19 14:30 UTC2026-02N050672-002CEFTINEQ 250MG BASE/5MLFOR SUSPENSION / ORALRLD1997-04-29011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N050672-001CEFTINEQ 125MG BASE/5MLFOR SUSPENSION / ORALRLD1994-06-3031067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N050672-002CEFTINEQ 250MG BASE/5MLFOR SUSPENSION / ORALRLD1997-04-2931067a03dcf5…
2025-08-23 18:47 UTC2025-08N050672-001CEFTINEQ 125MG BASE/5MLFOR SUSPENSION / ORALRLD1994-06-306a471c1ec25d…
2025-08-23 18:47 UTC2025-08N050672-002CEFTINEQ 250MG BASE/5MLFOR SUSPENSION / ORALRLD1997-04-296a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N050672-001CEFTINEQ 125MG BASE/5MLFOR SUSPENSION / ORALRLD1994-06-30fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N050672-002CEFTINEQ 250MG BASE/5MLFOR SUSPENSION / ORALRLD1997-04-29fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N050672-001CEFTINEQ 125MG BASE/5MLFOR SUSPENSION / ORALRLD1994-06-30b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N050672-002CEFTINEQ 250MG BASE/5MLFOR SUSPENSION / ORALRLD1997-04-29b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N050672-001CEFTINEQ 125MG BASE/5MLFOR SUSPENSION / ORALRLD1994-06-3003ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N050672-002CEFTINEQ 250MG BASE/5MLFOR SUSPENSION / ORALRLD1997-04-2903ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N050672-001CEFTINEQ 125MG BASE/5MLFOR SUSPENSION / ORALRLD1994-06-302680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N050672-002CEFTINEQ 250MG BASE/5MLFOR SUSPENSION / ORALRLD1997-04-292680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N050672-001CEFTINEQ 125MG BASE/5MLFOR SUSPENSION / ORALRLD1994-06-305bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N050672-002CEFTINEQ 250MG BASE/5MLFOR SUSPENSION / ORALRLD1997-04-295bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N050672-001CEFTINEQ 125MG BASE/5MLFOR SUSPENSION / ORALRLD1994-06-30d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N050672-002CEFTINEQ 250MG BASE/5MLFOR SUSPENSION / ORALRLD1997-04-29d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N050672-001CEFTINEQ 125MG BASE/5MLFOR SUSPENSION / ORALRLD1994-06-30d06236e962d9…
2024-10-29 15:01 UTC2024-10N050672-002CEFTINEQ 250MG BASE/5MLFOR SUSPENSION / ORALRLD1997-04-29d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N050672-001CEFTINEQ 125MG BASE/5MLFOR SUSPENSION / ORALRLD1994-06-3079d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N050672-002CEFTINEQ 250MG BASE/5MLFOR SUSPENSION / ORALRLD1997-04-2979d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N050672-001CEFTINEQ 125MG BASE/5MLFOR SUSPENSION / ORALRLD1994-06-30301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N050672-002CEFTINEQ 250MG BASE/5MLFOR SUSPENSION / ORALRLD1997-04-29301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N050672-001CEFTINEQ 125MG BASE/5MLFOR SUSPENSION / ORALRLD1994-06-301e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N050672-002CEFTINEQ 250MG BASE/5MLFOR SUSPENSION / ORALRLD1997-04-291e350fbaab3a…
2024-05-31 18:47 UTC2024-05N050672-001CEFTINEQ 125MG BASE/5MLFOR SUSPENSION / ORALRLD1994-06-308072bd15b7f6…
2024-05-31 18:47 UTC2024-05N050672-002CEFTINEQ 250MG BASE/5MLFOR SUSPENSION / ORALRLD1997-04-298072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N050672-001CEFTINEQ 125MG BASE/5MLFOR SUSPENSION / ORALRLD1994-06-305c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N050672-002CEFTINEQ 250MG BASE/5MLFOR SUSPENSION / ORALRLD1997-04-295c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N050672-001CEFTINEQ 125MG BASE/5MLFOR SUSPENSION / ORALRLD1994-06-305d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N050672-002CEFTINEQ 250MG BASE/5MLFOR SUSPENSION / ORALRLD1997-04-295d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N050672-001CEFTINEQ 125MG BASE/5MLFOR SUSPENSION / ORALRLD1994-06-304b0b4de00fa7…
2022-04-04 05:41 UTC2022-04N050672-002CEFTINEQ 250MG BASE/5MLFOR SUSPENSION / ORALRLD1997-04-294b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N050672-001CEFTINEQ 125MG BASE/5MLFOR SUSPENSION / ORALRLD1994-06-3074a2ff9319b5…
2019-12-13 00:20 UTC2019-12N050672-002CEFTINEQ 250MG BASE/5MLFOR SUSPENSION / ORALRLD1997-04-2974a2ff9319b5…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 32 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Cefuroxime AxetilCEFUROXIME AXETILREMEDYREPACK INC.76cec54f-d167-4298-951b-5411a3c47f4a2026-08-05Warnings, Adverse reactionsName fallback
generic name: CEFUROXIME AXETIL
Cefuroxime AxetilCEFUROXIME AXETILRedpharm Drug56cb6f42-9ae1-38e7-e063-6294a90a3feb2026-07-31Warnings, Adverse reactionsName fallback
generic name: CEFUROXIME AXETIL
Cefuroxime AxetilCEFUROXIME AXETILA-S Medication Solutions85cdd8d9-557e-4d15-855a-027e7809cf642026-05-14Warnings, Adverse reactionsName fallback
generic name: CEFUROXIME AXETIL
Cefuroxime AxetilCEFUROXIME AXETILA-S Medication Solutionsd14d4184-3e29-43cd-8046-658699c70f032026-05-14Warnings, Adverse reactionsName fallback
generic name: CEFUROXIME AXETIL
Cefuroxime axetilCEFUROXIME AXETILGolden State Medical Supply, Inc.bb7955fe-5111-1662-e053-2a95a90a85a12026-04-23Warnings, Adverse reactionsName fallback
generic name: CEFUROXIME AXETIL
Cefuroxime axetilCEFUROXIME AXETILNuCare Pharmaceuticals, Inc.4e4426a4-0ca9-dad5-e063-6294a90a5fdb2026-03-30Warnings, Adverse reactionsName fallback
generic name: CEFUROXIME AXETIL
Cefuroxime AxetilCEFUROXIME AXETILPD-Rx Pharmaceuticals, Inc.a84ac4ed-c268-4e9f-9df8-256e0a64cd162026-03-18Warnings, Adverse reactionsName fallback
generic name: CEFUROXIME AXETIL
Cefuroxime AxetilCEFUROXIME AXETILA-S Medication Solutionsa940ba01-2b53-4947-9019-d3d8f4e9ad802026-01-23Warnings, Adverse reactionsName fallback
generic name: CEFUROXIME AXETIL
Cefuroxime axetilCEFUROXIME AXETILAdvanced Rx of Tennessee, LLC48d96608-d3da-b512-e063-6294a90a07d52026-01-16Warnings, Adverse reactionsName fallback
generic name: CEFUROXIME AXETIL
Cefuroxime axetilCEFUROXIME AXETILRedpharm Drug3744f28c-c7e1-259c-e063-6294a90a10ed2025-12-11Warnings, Adverse reactionsName fallback
generic name: CEFUROXIME AXETIL
Cefuroxime axetilCEFUROXIME AXETILPD-Rx Pharmaceuticals, Inc.2af8f061-c0e1-3a1c-e054-00144ff8d46c2025-10-15Warnings, Adverse reactionsName fallback
generic name: CEFUROXIME AXETIL
Cefuroxime axetilCEFUROXIME AXETILPD-Rx Pharmaceuticals, Inc.2af94304-8118-41c7-e054-00144ff8d46c2025-10-15Warnings, Adverse reactionsName fallback
generic name: CEFUROXIME AXETIL
Cefuroxime AxetilCEFUROXIME AXETILA-S Medication Solutionsaa6685c1-51ed-466a-ae7f-89a82986a7b12025-10-08Warnings, Adverse reactionsName fallback
generic name: CEFUROXIME AXETIL
Cefuroxime AxetilCEFUROXIME AXETILA-S Medication Solutions119c4d09-2324-498f-9318-1f8db49ad4b62025-10-08Warnings, Adverse reactionsName fallback
generic name: CEFUROXIME AXETIL
Cefuroxime axetilCEFUROXIME AXETILAscend Laboratories, LLCdd11e4b9-7730-4d3a-81ca-16f15de097592025-10-03Warnings, Adverse reactionsName fallback
generic name: CEFUROXIME AXETIL
Cefuroxime AxetilCEFUROXIME AXETILNuCare Pharmaceuticals, Inc.3f92c452-18b4-5af8-e063-6394a90aaa532025-09-24Warnings, Adverse reactionsName fallback
generic name: CEFUROXIME AXETIL
Cefuroxime axetilCEFUROXIME AXETILMajor Pharmaceuticals44e1fb4d-4b61-40da-9974-0bd2006eb8282025-09-12Warnings, Adverse reactionsName fallback
generic name: CEFUROXIME AXETIL
Cefuroxime axetilCEFUROXIME AXETILAmerican Health Packagingf38418a7-dd90-4f20-b747-7ac086c530152025-08-06Warnings, Adverse reactionsName fallback
generic name: CEFUROXIME AXETIL
Cefuroxime AxetilCEFUROXIME AXETILPreferred Pharmaceuticals Inc.bc9200d2-4a6d-4847-ba85-8e9d378390de2025-07-31Warnings, Adverse reactionsName fallback
generic name: CEFUROXIME AXETIL
Cefuroxime axetilCEFUROXIME AXETILPD-Rx Pharmaceuticals, Inc.15cabe73-f39d-4798-a840-115fe94f8f962025-03-13Warnings, Adverse reactionsName fallback
generic name: CEFUROXIME AXETIL

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
66687SUPPL2021-03-09
66663SUPPL2021-03-09
58435SUPPL2019-04-26
50085SUPPL2017-10-18
50072SUPPL2017-10-17
45976SUPPL2016-12-01
45951SUPPL2016-11-23
30257SUPPL2015-08-28
18002SUPPL2015-08-27
30256SUPPL2015-07-07
39091SUPPL2015-07-01
30255SUPPL2014-09-23
30254SUPPL2014-09-23
39090SUPPL2014-09-22
39089SUPPL2014-09-22
39088SUPPL2007-08-02
7968SUPPL2007-08-02
39087SUPPL2004-06-07
30253SUPPL2004-06-07
30252SUPPL2002-04-11
18001SUPPL2002-04-11
18000SUPPL2002-03-29
7967SUPPL2002-03-29
30251SUPPL1999-08-24
22176SUPPL1999-08-24